KELLY MALONE: Open Payments
NPI 1417173139 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 14 payments from 5 companies in 2025. Trend: 2023 $47 · 2024 $247 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 5 | $184 |
| AstraZeneca Pharmaceuticals LP | 4 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $111 |
| Gilead Sciences, Inc. | 3 | $47 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
Products named: Barostim Neo System, Kerendia, WAINUA, Trodelvy, FARXIGA, LEQVIO.
Industry payments across AR — which companies pay providers there.
